跳至主要内容

CAS:80790-40-5|Cholecystokinin Octapeptide (1-4) (desulfated)|DYMG

Contact：
Liven Qian(钱叶华)-Custom Peptide
Mobile: 13761298676（微信）
Email：cps037@chinapeptides.net
QQ：2880526724
ChinaPeptides Co., Ltd./强耀生物科技有限公司

NameCholecystokinin Octapeptide (1-4) (desulfated)
Code[80790-40-5]
The aliasCholecystokinin Octapeptide (1-4) (desulfated)
Sequence (single letter abbreviation)DYMG
Sequence (three-letter abbreviation)Asp-Tyr-Met-Gly
A basic description
solubility
The molecular weight484.53
Chemical formulaC20H28N4O8S
The purity80%，90%，95%，98%，99%
Weight1mg,5mg,10mg,50mg,100mg,1g
Storage conditionsStore at -20°C. Keep tightly closed. Store in a cool dry place.



标签：

评论

  1. creative peptides2018年12月25日 06:51

    Cholecystokinin tetrapeptide (CCK-4, also PTK7) is a peptide fragment derived from the larger peptide hormone cholecystokinin. CCK-4 acts primarily in the brain as an anxiogenic, although it does retain some GI effects, but not as much as CCK-8 or the full length polypeptide CCK-58. CCK-4 Acetate

    回复删除

发表评论

此博客中的热门博文

Micellar nanoformulation of lipophilized bortezomib: high drug loading, improved tolerability and targeted treatment of triple negative breast cancer

文献作者：Kaiqi Wu, Ru Cheng, Jian Zhang, Fenghua Meng,  Chao Denga and Zhiyuan Zhong     《Journal of Materials Chemistry B》 ABSTRACTS Bortezomib (BTZ) is the first proteasome inhibitor approved for the treatment of malignant tumors. The current clinical formulation, however, shows fast clearance, low tumor accumulation, and several side effects. Here, we report that micellar nanoformulation of lipophilized bortezomib achieves significantly enhanced drug loading, prolonged circulation time, improved tolerability and targeted treatment of triple negative breast cancer  in vivo . Lipophilized bortezomib, bortezomib-pinanediol (BP), was readily prepared in high yield. Interestingly, cRGD-targeted micelles based on poly(ethylene glycol)- b -poly(trimethylene carbonate- co -dithiolane trimethylene carbonate) achieved a high drug loading content of 8.05 wt% BTZ equiv. for BP, which was more than 8-fold higher than BTZ. BP-loaded cRGD-decorated micelles (B...
发表评论
阅读全文

The targeted antioxidant MitoQ causes mitochondrial swelling and depolarization in kidney tissue

Author：Esther M. Gottwald, Michael Duss, Milica Bugarski,  Dominik Haenni, Claus D. Schuh, Ehud M. Landau, Andrew M. Hall     《Physiological Reports》 ABSTRACTS Kidney proximal tubules (PTs) contain a high density of mitochondria, which are required to generate ATP to power solute transport. Mitochondrial dysfunction is implicated in the pathogenesis of numerous kidney diseases. Damaged mitochondria are thought to produce excess reactive oxygen species (ROS), which can lead to oxidative stress and activation of cell death pathways. MitoQ is a mitochondrial targeted antioxidant that has shown promise in preclinical models of renal diseases. However, recent studies in nonkidney cells have suggested that MitoQ might also have adverse effects. Here, using a live imaging approach, and both in  vitro and ex  vivo models, we show that MitoQ induces rapid swelling and depolarization of mitochondria in PT cells, but these effects were not observed with S...
发表评论
阅读全文

Near-infrared light-activated red-emitting upconverting nanoplatform for T1-weighted magnetic resonance imaging and photodynamic therapy

Author：Xiang-long Tang, Jun Wu, Ben-lan Lin, Sheng Cui, Hong-mei Liu, Ru-tong Yu, Xiao-dong Shen, Ting-wei Wang, Wei Xia     《Acta Biomaterialia》 ABSTRACTS Photodynamic therapy (PDT) has increasingly become an efficient and attractive cancer treatment modality based on reactive oxygen species (ROS) that can induce tumor death after  irradiation   with ultraviolet or visible light. Herein, to overcome the limited tissue penetration in traditional PDT, a novel near-infrared (NIR) light-activated NaScF4: 40% Yb, 2% Er@CaF2  upconversion  nanoparticle   (rUCNP) is successfully designed and synthesized.  Chlorin   e6, a  photosensitizer   and a chelating agent for Mn2+, is loaded into  human serum albumin   (HSA) that further conjugates onto rUCNPs. To increase the ability to target glioma tumor, an acyclic  Arg–Gly–Asp peptide   (cRGDyK) is linked to rUCNPs@HSA(Ce6-Mn). This nanoplatform enables e...
发表评论
阅读全文